These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1220301)

  • 1. [Spirographic evaluation of obstructive ventilation disorders].
    Schindl R; Mayer K; Aigner K
    Wien Med Wochenschr; 1975 Jul; 125(28-31):449-52. PubMed ID: 1220301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 3. A simple spirometric clue to asthma: airways obstruction suggested by negative or reduced forced expiratory reserve volume despite normal FEV1-FVC ratio.
    Miller A
    Mt Sinai J Med; 1990 Mar; 57(2):85-92. PubMed ID: 2366769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirometric diagnosis of upper airway obstruction.
    Owens GR; Murphy DM
    Arch Intern Med; 1983 Jul; 143(7):1331-4. PubMed ID: 6870404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of airway obstruction: which test is best?
    Sobol BJ
    Proc R Soc Med; 1971 Dec; 64(12):1246-8. PubMed ID: 5131276
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics.
    Boggs PB; Bhat KD; Vekovius WA; Debo MS
    Ann Allergy; 1982 Mar; 48(3):139-42. PubMed ID: 7065476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of Berotec (Th1165a) and Salbutamol aerosols.
    McLeod J; Selman J
    N Z Med J; 1973 Sep; 78(498):209-10. PubMed ID: 4519004
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetic/pharmacodynamic modeling of theophylline in patients with different degrees of airway obstruction.
    Flores-Murrieta FJ; Mercado DE; Rodríguez-Silverio J; Chapela R
    Proc West Pharmacol Soc; 1999; 42():3-4. PubMed ID: 10697671
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of airway obstruction in epidemiological surveys by means of flow-volume curves.
    Niermeyer P; Quanjer PH; van der Lende R; Tammeling GJ
    Bull Physiopathol Respir (Nancy); 1972; 8(1):134-6. PubMed ID: 5052497
    [No Abstract]   [Full Text] [Related]  

  • 10. Sympathomimetic xanthine broncholysis in obstructive ventilatory disorders.
    Cohen BM; Elizabeth NJ
    Int J Clin Pharmacol; 1974 Jan; 9(1):6-15. PubMed ID: 4593130
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of FEV6 in the detection of airway obstruction.
    Crapo RO
    Respir Med; 2005 Nov; 99(11):1467. PubMed ID: 16098724
    [No Abstract]   [Full Text] [Related]  

  • 12. ["CO-diffusion capacity" and blood gases in obstructive airway diseases and their behavior under bronchodilator therapy].
    Siemon G; Thoma R; Keller R
    Verh Dtsch Ges Inn Med; 1974; 80():906-8. PubMed ID: 4454686
    [No Abstract]   [Full Text] [Related]  

  • 13. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 14. [The reliability of the maximal expiratory flow 25-75o/o referred to the vital capacity (MMEF 25-75/VC) in the detection of peripheral ventilatory disorders].
    Wipf R; Stinghe R
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1868-9. PubMed ID: 7455658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods for the study of reversible bronchial obstruction].
    Bianco S; Robuschi M; Petrigni G
    Arch Monaldi Mal Torace; 1989; 44(4-6):503-9. PubMed ID: 2577765
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
    Stauder J; Flasch CI
    Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the bronchodilatory action of two drugs.
    Prime FJ; Kamburoff PL; Günthner W
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):293-6. PubMed ID: 4402115
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional study of the bronchodilator effect of a new beta-2-stimulant (terbutaline) administered subcutaneously].
    Petraglia A; Gramazio A
    Arch Monaldi; 1976; 31(5-6):434-42. PubMed ID: 1031587
    [No Abstract]   [Full Text] [Related]  

  • 19. An easy method of spirometry.
    Meenakshi S; Gajalakshmi BS
    J Assoc Physicians India; 1993 May; 41(5):284-6. PubMed ID: 8300462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A; Szalai Z; Pullerits T; Radeczky E
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.